While Palantir Technologies continues to post explosive growth figures in its home market, the data analytics firm is encountering mounting resistance across Europe. A strategic shift in British government procurement and exclusion from sustainable investment funds on the continent are creating significant challenges for its international public sector ambitions.
Operational Strength Contrasts with Regulatory Pressure
The company’s latest financial results underscore its robust operational momentum. For the fourth quarter of 2025, Palantir reported a 70% year-over-year surge in total revenue, reaching $1.41 billion. Its US business was particularly strong, expanding by 93% to $1.08 billion in the same period.
Despite these powerful fundamentals, investor sentiment showed caution. Shares declined by 2.57% to €130.62 in Friday’s trading session. Market observers note the equity carries an extremely rich valuation, with a price-to-earnings ratio significantly above 200, making it sensitive to any negative developments in its overseas operations.
UK Policy Shift Threatens Key Contracts
A major source of those potential headwinds originates in the United Kingdom. The British government, through Science Minister Patrick Vallance, has announced a new procurement strategy designed to favor domestic software providers. This policy realignment directly jeopardizes Palantir’s existing agreements with UK public bodies.
Should investors sell immediately? Or is it worth buying Palantir?
One contract under particular scrutiny is for the National Health Service (NHS) data platform. Valued at approximately £182.2 million, this deal is currently set to run until February 2027. However, members of parliament are now examining avenues to terminate the agreement early to facilitate a switch to British alternatives. This review coincides with parliamentary questions regarding an unminuted meeting between Palantir executives and government officials that took place in February 2025.
ESG Concerns and Strategic Recalibration
Resistance is also emerging within the European financial sector. According to media reports, Belgian banks have initiated the removal of Palantir securities from their sustainable investment funds (ESG). Ongoing controversies surrounding the company’s business practices are cited as the rationale. This move signals a form of localized opposition that could complicate further expansion into European public sector contracts.
In response to these international pressures, Palantir’s leadership is intensifying its focus on the US re-industrialization theme. Chief Technology Officer Shyam Sankar has positioned artificial intelligence as a central lever for dramatically boosting American worker productivity. He illustrated this by citing a submarine parts manufacturer that used the company’s software to reduce production planning from two weeks to just ten minutes. This strategic emphasis aligns with US government incentive programs like the CHIPS Act, framing Palantir’s technology as a critical component for rebuilding domestic industrial capacity.
Ad
Palantir Stock: Buy or Sell?! New Palantir Analysis from March 21 delivers the answer:
The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 21.
Palantir: Buy or sell? Read more here...









